Related Experiment Video
Updated: Jul 15, 2025

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
Activation of Wnt Pathway Suppresses Growth of MUG-Chor1 Chordoma Cell Line
Hatice Burcu Şişli1, Taha Bartu Hayal1, Selinay Şenkal1
1Faculty of Engineering, Genetics and Bioengineering Department, Yeditepe University, İstanbul, 34755, Turkey.
Abstract:
Chordoma as a malignant bone tumor, occurs along the axial skeleton and does not have an effective therapy. Brachyury, which is a crucial player for the formation of early embryonic notochord, is abundantly found in both sporadic and familial chordoma. During embryonic development, Brachyury expression was reported to be regulated by the Wnt pathway. The objective of the study is to investigate the role of Wnt signaling in a human chordoma cell line in terms of proliferation, survival, and invasiveness. We tried to elucidate the signaling events that regulate Chordoma cancer. In this regard, Wnt pathway was activated or inhibited using various strategies including small molecules, siRNA-based knockdown and overexpression applications. The results indicated the negative regulatory effect of Wnt signaling activity on proliferation and migration capacity of the chordoma cells. It was revealed that when GSK3β was inhibited, the Wnt pathway was activated and negatively regulated T/Bra expression. Activity of the Wnt pathway caused cell cycle arrest, reduced migration potential of the cells, and led to cell death. Therefore, the present study suggests that the Wnt pathway plays a key role in suppressing the proliferation and invasive characteristics of human chordoma cells and has a great potential as a therapeutic target in further clinical studies.
Insights
The Wnt pathway suppresses chordoma cell proliferation and invasion. Activating this pathway can lead to cell cycle arrest, reduced migration, and cell death, offering a potential therapeutic target for this bone cancer.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Chordoma is an aggressive bone tumor of the axial skeleton lacking effective treatments.
- Brachyury, a key embryonic notochord protein, is highly expressed in chordoma.
- Wnt signaling is implicated in embryonic Brachyury regulation.
Purpose of the Study:
- To investigate the role of Wnt signaling in human chordoma cell proliferation, survival, and invasiveness.
- To elucidate signaling events regulating chordoma cancer.
- To explore Wnt pathway modulation as a therapeutic strategy.
Main Methods:
- Chordoma cell line manipulation using small molecules, siRNA knockdown, and overexpression.
- Activation and inhibition of the Wnt signaling pathway.
- Assessment of cell proliferation, migration, cell cycle, and apoptosis.
Main Results:
- Wnt pathway activation, induced by GSK3β inhibition, negatively regulated T/Brachyury (T/Bra) expression.
- Activated Wnt signaling suppressed chordoma cell proliferation and migration.
- Wnt pathway activity resulted in cell cycle arrest and induced cell death.
Conclusions:
- The Wnt pathway plays a significant role in inhibiting chordoma cell proliferation and invasiveness.
- Modulating Wnt signaling presents a promising therapeutic target for chordoma treatment.
- Further clinical studies are warranted to explore Wnt pathway-based therapies.
Related Concept Videos
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Hedgehog Signaling Pathway

